GLP-1 / GIP / Glucagon Tri-Agonist
RT-3
In preclinical models, RT-3 has demonstrated a synergistic effect on weight reduction and hepatic fat clearance via triple-receptor agonism. In vitro data suggests significant potency at the GIP receptor.
Free shipping
on orders over $150
Damage protection
included with every order
Secure checkout
256-bit SSL encryption
Purity
≥ 98%
Molecular
≈ 4,731.33 g/mol
Formula
C₂₂₁H₃₄₂N₄₆O₆₈
Research Applications
Utilized in metabolic research as a triple agonist targeting GIP, GLP-1, and Glucagon receptors. Primary research focuses include the study of hepatic lipid reduction in MASLD/MASH models, energy expenditure acceleration, and glycemic control in obesity-induced diabetes models.
Key Technical Properties
- 39-amino acid synthetic peptide
- C₂₀ fatty diacid moiety for albumin binding
- High-affinity triple receptor agonism
Storage & Handling
Lab Name
Verified Research Lab
Store at -20°C to -80°C in desiccated, light-protected vials.
Reconstituted Solution
Store at 2–8°C for short-term use; aliquot and freeze at -80°C for long-term stability.
Caution: Avoid aggressive vortexing.
Mandatory Compliance Notice
This product is intended strictly for laboratory research purposes only. It is not intended for human use, clinical diagnostics, or any form of therapeutic application. By accessing this information, the researcher acknowledges that these compounds are for in vitro or animal model studies only. Any use contrary to these guidelines is strictly prohibited.